CORD-19:2e2bc679c8393230bac2af64115bab7ed1ba62c0 / 36841-36916 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2e2bc679c8393230bac2af64115bab7ed1ba62c0","sourcedb":"CORD-19","sourceid":"2e2bc679c8393230bac2af64115bab7ed1ba62c0","text":"With the rifampicin, 27.27% of the patients of group 2 presented cytolysis.","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T267","span":{"begin":0,"end":75},"obj":"Sentence"}],"attributes":[{"subj":"T267","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T267","span":{"begin":0,"end":75},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T267","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#e9ec93","default":true},{"id":"CORD-19-Sentences","color":"#d593ec"}]}]}}